Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New predictive approaches for ITI treatment.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2014

Minno G D, Santagostino E, Pratt K, Königs C

Abstract excerpt

Immune tolerance induction (ITI) therapy in patients with haemophilia A and inhibitors constitutes a huge burden for affected patients and families and poses a large economic burden for a chronic disease. Concerted research efforts are attempting to optimize the therapeutic approach to the prevention and eradication of inhibitors. The Italian ITI Registry has provided data on 110 patients who completed ITI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Tolerance
Share to Italy
Share to Registries

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B-Lymphocytes

Share to Blood Coagulation Factor Inhibitors

Share to Coagulants

Share to Factor VIII

Share to Hemophilia A

Source

Identifiers

PMID: 24975702
DOI: 10.1111/hae.12467

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New predictive approaches for ITI treatment.PMID 24975702Read ↗

Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A.Semantic proximity Read ↗

Immune tolerance induction in patients with hemophilia A.Semantic proximity Read ↗

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Semantic proximity Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.Semantic proximity Read ↗

Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': predictive parameter for therapy duration and outcome.Semantic proximity Read ↗

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.Semantic proximity Read ↗

Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.Semantic proximity Read ↗

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.Semantic proximity Read ↗

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.Semantic proximity Read ↗

Key insights to understand the immunogenicity of FVIII products.Semantic proximity Read ↗

Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.